Company intelligence / Profile preview

BennuBio

Albuquerque, New Mexico, United States

Ownership: Private
Development stage: Other

Overview

BennuBio has developed and commercialized the Velocyt flow cytometer, enabling ultra-high throughput analysis of particles ranging from single cells to large clusters, spheroids, and organoids, supporting biomedical research, drug discovery, and process monitoring

Modalities: Device
Industry: Pathology

Partnerships

Technology licensed from University of New Mexico through STC.UNMinvestments from Tramway Venture PartnersCottonwood Technology FundSun Mountain Capital

Beyond the preview

Go deeper on BennuBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BennuBio.

Explore the full profile